You are Here: Drug LitigationPradaxa

Pradaxa: A Brief Overview:

For those patients with heart valve problems or atrial fibrillation who are at a significantly elevated risk of stroke, the drug Pradaxa (Dabigatran), approved by the FDA merely twenty-eight months ago appeared to be a good solution to these medical issues. Pradaxa (Dabigatran) falls under a group of drugs known as direct thrombonin inhibitors which work by limiting the actions of a specific blood enzyme which is crucial to the blood clotting process. Pradaxa (Dabigatran) is indicated for use as an anti-coagulant, along the lines of the drug Warfarin, although the makers of Pradaxa (Dabigatran), Boehringer Ingelhem, claim their drug is at least 35% more effective in reducing the risk of stroke than Warfarin. Since the kidneys are responsible for expelling Pradaxa (Dabigatran) from the body, increased quantities of the drug can remain in the body when kidney function is not optimal, leading to potential bleeding problems.


Pradaxa: A Brief Overview:

For those patients with heart valve problems or atrial fibrillation who are at a significantly elevated risk of stroke, the drug Pradaxa (Dabigatran), approved by the FDA merely twenty-eight months ago appeared to be a good solution to these medical issues. Pradaxa (Dabigatran) falls under a group..... More...

Pradaxa: The FDA’s Stance:

Pradaxa (Dabigatran) is a blood-thinning drug which is prescribed to reduce the elevated risk of stroke among patients who suffer from heart valve problems or atrial fibrillation. Pradaxa (Dabigatran) is the first drug in its class to gain FDA approval in nearly sixty years, since the drug Warfarin—also known.... More...

The Dangers of Pradaxa: Cerebral Hemorrhage, Internal Bleeding, and Death.

Pradaxa (Dabigatran) is the “new kid on the block” prescription drug used in the treatment of heart valve problems or atrial fibrillation in those who have an elevated risk of stroke. Pradaxa (Dabigatran) was given the FDA green light.... More...

Pradaxa Lawsuits: Do I Have a Case?

While Pradaxa (Dabigatran) did not gain U.S. FDA approval until October of 2010, it became the subject of a New Zealand investigation in September, 2011, after five elderly patients died from severe internal bleeding. The relatives of those patients noted that adverse side effects began when their loved ones.... More...

How We Can Help:

If you have been the victim of a drug which caused death or serious harm to you or a loved one you may be confused about whether you need the services of a personal injury attorney. You want the best outcome possible for adverse health events caused by drugs such as Pradaxa (Dabigatran).... More...


Free Consultation  Call Now

Get Interactive

Sullo & Sullo-Facebook Sullo & Sullo-Linkedin Sullo & Sullo-Twitter Sullo & Sullo-You Tube
 
Free Consultation
Receive an immediate response to your request.
Choose the practice area your problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy

CAPTCHA image

Recent Articles & Publications

November 25, 2013
Iclusig, a drug manufactured by Ariad Pharmaceuticals to treat resistant chronic myeloid leukemia, gained FDA approval last December—almost three months ahead of the anticipated...

November 22, 2013
Sales of Iclusig, a drug used primarily in the treatment of chronic myeloid leukemia, were recently suspended in a joint decision between the FDA and Ariad Pharmaceuticals,...

November 20, 2013
Recently, Ariad Pharmaceuticals and the FDA have jointly decided to suspend sales of Iclusig, a drug used in the treatment of chronic myeloid leukemia and Philadelphia chromosome...